Abstract Objective The non-classical, human MHC-I molecule HLA-E is functionally monomorphic and therefore a highly attractive target in immunotherapy against cancers and infectious diseases. However, HLA-E is characterized by low stability due to its biological role as a rapid-response system to monitor HLA-I expression. The inherent instability makes production of HLA-E difficult and severely limits its use as a reagent, which in turn negatively impacts the understanding of HLA-E biology. Here, we present native-like, stabilized forms of HLA-E, which brings production of HLA-E in line with that of classical MHC-I molecules. Methods Disulfide bridges were introduced in HLA-E at selected locations deemed to not interfere with recognition of HLA-E by NK or T cell receptors. The stability of the modified HLA-E molecules was monitored using thermal denaturation, and conservation of native HLA-E properties was assessed by in vitro TCR-binding assays and through staining of NK cells. Results The modified HLA-E molecules exhibited increased stability, increased refolding yields, both or neither. The most stable HLA-E variant exhibited thermal stability comparable to complexes of HLA-A*02:01, while retaining native-like recognition by both NK and T cell receptors. Summary Stabilized forms of HLA-E have been generated and their native-like properties validated using in vitro assays and NK cell staining. This enables production of reagents for the study HLA-E biology.
Read full abstract